Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
24.2M
-
Shares change
-
+267K
-
Total reported value, excl. options
-
$294M
-
Value change
-
+$2.43M
-
Put/Call ratio
-
0
-
Number of buys
-
46
-
Number of sells
-
-48
-
Price
-
$12.25
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2014
112 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q3 2014.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.2M shares
of 37.4M outstanding shares and own 64.58% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (2.63M shares), GUGGENHEIM CAPITAL LLC (2.54M shares), DIMENSIONAL FUND ADVISORS LP (2.15M shares), ARIEL INVESTMENTS, LLC (1.81M shares), KILLEN GROUP INC (1.34M shares), Opus Capital Group, LLC (1.04M shares), Boston Partners (994K shares), BlackRock Institutional Trust Company, N.A. (961K shares), ROYAL BANK OF CANADA (937K shares), and NWQ INVESTMENT MANAGEMENT COMPANY, LLC (867K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.